Literature DB >> 2174071

Late-onset globoid cell leukodystrophy: unusual ultrastructural pathology and subtotal beta-galactocerebrosidase deficiency.

H H Goebel1, K Harzer, J P Ernst, J Bohl, H Klein.   

Abstract

An 11-year-old girl was found to have severely reduced beta-galactocerebrosidase activity as evidence of late-onset globoid cell leukodystrophy, while her mother had almost normal enzyme activity in circulating white blood cells. Clinically, the patient showed a remitting course marked by seizures, ataxia, white-matter disease on computed tomographic scan, and reduced conduction velocities of peripheral nerves. Symptoms improved somewhat around the age of 10 years. Two sural nerve biopsies, performed 6 years apart, disclosed a demyelinating neuropathy. By electron microscopy, membrane-bound vacuolar lysosomes in Schwann cells of myelinated axons, unlike the typical needlelike inclusions seen in classic infantile globoid cell leukodystrophy, were present in both specimens. Thus, clinical, morphologic, and biochemical data in this patient--and her mother--emphasize, compared with past reports on late-onset globoid cell leukodystrophy, considerable variation in the nosologic spectrum of late-onset globoid cell leukodystrophy and conspicuous differences from classic infantile globoid cell leukodystrophy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174071     DOI: 10.1177/088307389000500405

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

Review 1.  Krabbe Disease in the Arab World.

Authors:  Hatem Zayed
Journal:  J Pediatr Genet       Date:  2015-03

Review 2.  The inherited leukodystrophies: a clinical overview.

Authors:  J Aicardi
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Adult Krabbe Disease That Was Successfully Treated with Intravenous Immunoglobulin.

Authors:  Ryosuke Fukazawa; Hiroki Takeuchi; Nobuyuki Oka; Toko Shibuya; Norio Sakai; Akihiro Fujii
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.